JPRN-UMIN000014488
Recruiting
未知
Pilot study of multimodality treatment based on a new risk stratification in patients with medulloblastoma - Pilot study based on a new risk stratification for medulloblastoma
Japanese Pediatric Brain Tumor Consortium0 sites30 target enrollmentAugust 1, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Japanese Pediatric Brain Tumor Consortium
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Has double cancer. 2\. Has cardiac disease for which treatment is necessary. 3\. Pregnant or nursing.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 2
WJOG11118JPRN-jRCTs041200046Hirotsugu Kenmotsu30
Active, not recruiting
Not Applicable
Pilot study - sequential combination therapy using selective immunoglobulin apheresis and omalizumab in patients with severe atopic dermatitis and elevated total IgE levelsPatients with severe Atopic dermatitis and total IgE-level > 700 IU/ml (potentially associated with bronchial asthma and/or allergic rhinitis)MedDRA version: 12.0Level: LLTClassification code 10002198Term: Anaphylactic reactionMedDRA version: 12.0Level: LLTClassification code 10040400Term: Serum sicknessMedDRA version: 12.0Level: LLTClassification code 10043554Term: ThrombocytopeniaMedDRA version: 12.0Level: LLTClassification code 10019211Term: HeadacheMedDRA version: 12.0Level: LLTClassification code 10028810Term: NasopharyngitisMedDRA version: 12.0Level: LLTClassification code 10040753Term: SinusitisMedDRA version: 12.0Level: LLTClassification code 10022000Term: InfluenzaMedDRA version: 12.0Level: LLTClassification code 10006451Term: BronchitisMedDRA version: 12.0Level: LLTClassification code 10017888Term: GastroenteritisMedDRA version: 12.0Level: LLTClassification code 10034835Term: PharyngitisMedDRA version: 12.0Level: LLTClassification code 10047461Term: Viral infectionMedDRA version: 12.0Level: LLTClassification code 10034844Term: Pharyngolaryngeal painMedDRA version: 12.0Level: LLTClassification code 10011224Term: CoughMedDRA version: 12.0Level: LLTClassification code 10039083Term: RhinitisMedDRA version: 12.0Level: LLTClassification code 10028735Term: Nasal congestionMedDRA version: 12.0Level: LLTClassification code 10039085Term: Rhinitis allergicMedDRA version: 12.0Level: LLTClassification code 10012727Term: DiarrheaMedDRA version: 12.0Level: LLTClassification code 10028813Term: NauseaMedDRA version: 12.0Level: LLTClassification code 10013946Term: DyspepsiaMedDRA version: 12.0Level: LLTClassification code 10003988Term: Back painMedDRA version: 12.0Level: LLTClassification code 10003239Term: ArthralgiaMedDRA version: 12.0Level: LLTClassification code 10028411Term:EUCTR2009-014582-51-DEFaculty of Medicine, Technische Universität München
Completed
Phase 2
A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung canceron-small cell lung cancerJPRN-UMIN000029435Department of respiratory medicine, Kurashiki Central Hospital20
Recruiting
Phase 2
A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumoron-metastatic Ewing Sarcoma Family TumorJPRN-UMIN000020903Japan Ewing Sarcoma Study Group66
Recruiting
Phase 2
JESS14Ewing sarcoma family tumorEwing sarcomaC04.557.450.565.575.650.800JPRN-jRCTs021180022Sano Hideki66